Alternatives to umeclidinium
3 same-class SPL records vs umeclidinium - uses, FAERS reaction fields, and OTC/Rx flags from public FDA sources.
Brand: Incruse Ellipta
About umeclidinium
Incruse Ellipta is a medicine that helps people with COPD breathe easier. It contains umeclidinium, which is a long-acting muscarinic antagonist (LAMA).
Used for: Incruse Ellipta is used to help people with chronic obstructive pulmonary disease (COPD) breathe better. COPD is a long-term lung disease that makes it hard to breathe. This medicine is not for sudden breathing problems or asthma.
3 Long-Acting Muscarinic Antagonist (LAMA) peers (wide set)
aclidinium
RxTudorza Pressair
glycopyrrolate
RxSeebri, Lonhala
This medicine can help reduce saliva and other secretions before surgery. It can also help control stomach acid. Glycopyrrolate can also treat peptic ulcers in adults when a quick effect is needed or when you can't take pills.
tiotropium
RxSpiriva
STIOLTO RESPIMAT is used to treat chronic obstructive pulmonary disease (COPD). COPD includes chronic bronchitis and emphysema. This medicine helps you breathe better over a long period. It is not for sudden breathing problems.
umeclidinium vs aclidinium & glycopyrrolate · FAERS reaction fields
FAERS top-reaction field "Asthma" shows the widest count spread between umeclidinium and aclidinium, glycopyrrolate, tiotropium in this extract (10,213-report gap on that field). Counts are exposure-weighted submissions, not prevalence rates.
| Side Effect | umeclidinium | aclidinium | glycopyrrolate | tiotropium |
|---|---|---|---|---|
| Dyspnoea | 1,352 | - | 1,000 | - |
| Cough | 701 | 655 | 626 | 8,611 |
| Asthma | 604 | 814 | 793 | 10,817 |
| Wrong Technique In Device Usage Process | 520 | - | - | - |
| Pneumonia | 509 | 692 | 538 | 8,380 |
| Chronic Obstructive Pulmonary Disease | 403 | - | 326 | - |
| Fatigue | 364 | - | 352 | - |
| Wheezing | 325 | 645 | 674 | 6,761 |
"-" means no reports for that reaction. Report counts reflect total FAERS submissions, not prevalence rates.
umeclidinium peer mix vs class inventory
Peer mix
0 OTC and 3 Rx SPL records in this peer set (3 total). Class inventory for Long-Acting Muscarinic Antagonist (LAMA): 4 drugs.
Frequently Asked Questions
What same-class SPL records sit beside umeclidinium? ▼
Reading a wide Long-Acting Muscarinic Antagonist (LAMA) peer set (3 records)
umeclidinium (Incruse Ellipta) sits in a wide Long-Acting Muscarinic Antagonist (LAMA) peer set (3 of 3 class peers shown). Labeled indication field for umeclidinium: Incruse Ellipta is used to help people with chronic obstructive pulmonary disease (COPD) breathe better.
Top FAERS reaction fields for umeclidinium total 5,414 reports across 10 reactions, set beside aclidinium, glycopyrrolate, tiotropium. Counts are exposure-weighted submissions, not per-patient risk.
Registry note: Therapeutic-class peer lists are registry indexes, not prescribing advice. This information is for educational purposes only and is not a substitute for professional medical advice. Do not stop or change your medication without talking to your doctor or pharmacist.
Field note for umeclidinium: see also the generic vs brand label guide when reading Incruse Ellipta SPL strings.
Read our methodology - how this data is sourced, computed, and verified.